| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.MCE.2011.07.008 |
| P698 | PubMed publication ID | 21802490 |
| P50 | author | Norman Maitland | Q37392064 |
| Anne Collins | Q77923959 | ||
| P2093 | author name string | Davide Pellacani | |
| Emma E Oldridge | |||
| P433 | issue | 1-2 | |
| P921 | main subject | prostate cancer | Q181257 |
| neoplastic stem cells | Q1638475 | ||
| P304 | page(s) | 14-24 | |
| P577 | publication date | 2011-07-23 | |
| P1433 | published in | Molecular and Cellular Endocrinology | Q1573600 |
| P1476 | title | Prostate cancer stem cells: are they androgen-responsive? | |
| P478 | volume | 360 |
| Q50920040 | Advanced prostate cancer--a case for adjuvant differentiation therapy. |
| Q36260616 | CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations. |
| Q36067956 | Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes |
| Q38642046 | DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation. |
| Q46033653 | Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts. |
| Q34766615 | Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells |
| Q35514837 | Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules |
| Q47253494 | Interleukin-4 induces a CD44high /CD49bhigh PC3 subpopulation with tumor-initiating characteristics. |
| Q35742477 | Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy |
| Q34365632 | Molecular pathways and targets in prostate cancer |
| Q44287808 | Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells |
| Q36328812 | Overcoming drug resistance and treating advanced prostate cancer |
| Q43623151 | Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer |
| Q33987121 | Prostate progenitor cells proliferate in response to castration |
| Q42154804 | Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts |
| Q26865693 | Targeting prostate cancer stem cells for cancer therapy |
| Q37148238 | The significance of galectin-3 as a new basal cell marker in prostate cancer |
| Q91957076 | The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells |
| Q26795611 | Therapy escape mechanisms in the malignant prostate |
Search more.